seqWell Inc.
Multiplexed NGS library preparation kits and workflows
- Sector
- Biotech
- Headquarters
- BEVERLY, MA
- Founded
- 2014
- Latest Form D
- $960K, Sep 2026
- Total capital
- $23.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $23.5M
- 9 Form D · last Sep 2026
- 2 months since last filing
- Federal contracts
- $10K
- 1 award · Health and Human S
- Rank in Biotech#383 of 4373
- Granted patents
- 1
- 22 pending · first 2026
- Rank in peer group#7 of 22
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 9th filing$960K
- Private capital raisedForm D · SEC · 8th filing$3.1M
- Private capital raisedForm D · SEC · 7th filing$12K
- Private capital raisedForm D · SEC · 6th filing$3K
- Private capital raisedForm D · SEC · 5th filing$3.4M
- Private capital raisedForm D · SEC · 4th filing$7M
- Federal contractHealth and Human S · This Product Will Be Used For Multiplexing Library Prep$10K
- Private capital raisedForm D · SEC · 3rd filing$7M
- Private capital raisedForm D · SEC · 2nd filing$700K
- Private capital raisedForm D · SEC · 1st filing$1.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 22 peers
Line = medianBiotech · Instrument
- Granted patents#7 · top 32%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Joseph MellorResearcherExecutive Officer, DirectorLinked by 1 patent
- Amy LiaoDirectorNamed in SEC Form D filings
- Anup ParikhDirectorNamed in SEC Form D filings
- Chad SouvignierDirectorNamed in SEC Form D filings
- Chad SoveignerDirectorNamed in SEC Form D filings
- Dan CalvoExecutive Officer, DirectorNamed in SEC Form D filings
Show all 15 people
- Daniel CalvoExecutive Officer, DirectorNamed in SEC Form D filings
- Jack LeonardExecutive OfficerNamed in SEC Form D filings
- Joseph Mellor, Ph.D.Executive Officer, DirectorNamed in SEC Form D filings
- Michael FinneyDirectorNamed in SEC Form D filings
- Paul McEwanDirectorNamed in SEC Form D filings
- Rob WilsonDirectorNamed in SEC Form D filings
- Thomas GrantExecutive OfficerNamed in SEC Form D filings
- Tom GrantExecutive OfficerNamed in SEC Form D filings
- William McKenzieDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 23- PendingMethods For Normalizing Nucleic Acid SamplesUSPTOApplication 19435166
- GrantedMethods For Normalizing Nucleic Acid SamplesUSPTOUS 12,540,320
- PendingKits And Methods For Preparation Of Nucleic Acid Libraries For SequencingUSPTOApplication 18697064
Show all 23 patent records
- Methods For Normalizing Nucleic Acid SamplesApr 30, 2026 · Application 19435166Pending
- Methods For Normalizing Nucleic Acid SamplesFeb 3, 2026 · US 12,540,320Granted
- Kits And Methods For Preparation Of Nucleic Acid Libraries For SequencingJan 30, 2025 · Application 18697064Pending
- Sequencing Oligonucleotides And Methods Of Use ThereofJan 11, 2024 · Application 18025343Pending
- Compositions And Methods For Sequencing Nucleic AcidsJan 2, 2020 · Application 16486091Pending
- Compositions And Methods For Sequencing Nucleic AcidsJun 6, 2019 · Application 16069603Pending
- Normalized Iterative Barcoding And Sequencing Of Dna CollectionsJan 11, 2018 · Application 15543305Pending
- Kits And Methods For Preparation Of Nucleic Acid Libraries For SequencingApplication PCTUS2022077273Pending
- Kits And Methods For Preparation Of Nucleic Acid Libraries For SequencingApplication 63249653Pending
- Sequencing Oligonucleotides And Methods Of Use ThereofApplication PCTUS2021049422Pending
- Sequencing Oligonucleotides And Methods Of Use ThereofApplication 63075682Pending
- Compositions And Methods For Sequencing Nucleic AcidsApplication PCTUS2018018235Pending
- Compositions And Methods For Sequencing Nucleic AcidsApplication 62458893Pending
- Compositions And Methods For Sequencing Nucleic AcidsApplication PCTUS2017013191Pending
- Compositions And Methods For Sequencing Nucleic AcidsApplication 62411399Pending
- Normalized Iterative Barcoding And Sequencing Of Dna CollectionsApplication PCTUS2016013753Pending
- Compositions And Methods For Sequencing DnaApplication 62277867Pending
- Methods And Kits For Preparing Engineered Nucleic AcidsApplication PCTUS2025055764Pending
- Libraries, Methods, And Kits For Index Color Balancing Nucleic AcidsApplication PCTUS2025053481Pending
- Engineered Transposases And Methods Of Use ThereofApplication PCTUS2025012432Pending
- Methods And Kits For Preparing Engineered Nucleic AcidsApplication 63721815Pending
- Libraries, Methods, And Kits For Index Color Balancing Nucleic AcidsApplication 63715287Pending
- Methods Of Using Engineered TransposasesApplication 63623064Pending
Related companies, and why
- SUPERIOR NANO LLCSimilar federal contract value in Biotech · $12K in contracts
- SPECTRAGENETICSSimilar federal contract value in Biotech · $11K in contracts
- Infinity Bio, Inc.Similar federal contract value in Biotech · $11K in contracts
- Full Genomes CorpSimilar federal contract value in Biotech · $10K in contracts
- Cellecta, IncorporatedSimilar federal contract value in Biotech · $9K in contracts
- Zenobia Therapeutics, Inc.Similar federal contract value in Biotech · $8K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .